Authors: Lev-Lehman, E Bercovich, D Xu, W Stockton, DW Beaudet, AL

Citation: E. Lev-lehman et al., Characterization of the human beta 4 nAChR gene and polymorphisms in CHRNA3 and CHRNB4, J HUM GENET, 46(7), 2001, pp. 362-366

Authors: Lev-Lehman, E Evron, T Broide, RS Meshorer, E Ariel, I Seidman, S Soreq, H

Citation: E. Lev-lehman et al., Synaptogenesis and myopathy under acetylcholinesterase overexpression, J MOL NEURO, 14(1-2), 2000, pp. 93-105

Authors: Fang, P Lev-Lehman, E Tsai, TF Matsuura, T Benton, CS Sutcliffe, JS Christian, SL Kubota, T Halley, DJ Meijers-Heijboer, H Langlois, S Graham, JM Beuten, J Willems, PJ Ledbetter, DH Beaudet, AL

Citation: P. Fang et al., The spectrum of mutations in UBE3A causing Angelman syndrome, HUM MOL GEN, 8(1), 1999, pp. 129-135

Authors: Nawaz, Z Lonard, DH Smith, CL Lev-Lehman, E Tsai, SY Tsai, MJ O'Malley, BW

Citation: Z. Nawaz et al., The Angelman syndrome-associated protein, E6-AP, is a coactivator for the nuclear hormone receptor superfamily, MOL CELL B, 19(2), 1999, pp. 1182-1189

Authors: Grisaru, D Lev-Lehman, E Shapira, M Chaikin, E Lessing, JB Eldor, A Eckstein, F Soreq, H

Citation: D. Grisaru et al., Human osteogenesis involves differentiation-dependent increases in the morphogenically active 3 ' alternative splicing variant of acetylcholinesterase, MOL CELL B, 19(1), 1999, pp. 788-795

Authors: Jiang, YH Lev-Lehman, E Bressler, J Tsai, TF Beaudet, AL

Citation: Yh. Jiang et al., Genetics of Angelman syndrome, AM J HU GEN, 65(1), 1999, pp. 1-6